UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

The role of dophamine in mechanisms of forming some disorders of central nervous system and dependent states (Review)

Authors

Type of Article

In the Section

Index UDK:

Abstract

Dophamine is the metabolic predecessor of norepinephrine and adrenaline, besides that, there is the own dophamine’s neuro transmitter function that causes the universal properties of dophamine. Dophamine takes part in pathogenesis and etiology of some neurological and psychiatric diseases such as Parkinson’s disease, Huntington’s chorea, Tourette syndrome, schizophrenia, anorexia neurosis, hyperactive defective disorder at children, the drug dependence on cocaine and amphetamines. The substances, that caused the syndrome of dependence, have the common pharmacological eff ect which displays in the infl uence on catecholamine neuromediation with mesocorticolimbical dophamine system as a basic link. During therapeutical compensation of the defi ciency state of dophaminergical system it is important to take into account the role of dophamine in forming the dependent states.

Pages

References

  1. Carlsson, A. A paradigm shift in brain research / А. Carlsson // Science. — 2001. — Vol. 294. — Р. 1021—1024.
  2. Nicola, S. M. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens / S. M. Nicola, D. J. Surmeier, R. C. Malenka // Annual Review of Neuroscience. — 2000. — Vol. 23. — P. 185—215.
  3. Raevsky, K. S. Functional role and pharmacological regulation of the dopaminergic system of the brain / K. S. Raevsky // Bulletin of the Russian Academy of Medical Sciences. - 1998. - VOL. 8. - PP. 19-24.
  4. Vasiliev, V. N. Sympathetic-adrenal activity in various functional states of man / V. N. Vasiliev, V. S. Chugunov. - Moscow: Medicine, 1985. - 272 с.
  5. The peripheral dopaminergic system: morphological analysis, functional and clinical applications / [F. Amenta, A. Ricci, S. K. Taybeati, D. Zaccheo] // Ital. J. Anat. Embriol. — 2002. — Vol. 107. — № 3. — P. 145—167.
  6. Kulinsky, V. I. Neurotransmitters and the brain / V. I. Kulinsky // Soros Educational Journal. - 2001. - Т. 7. - № 6. - С. 11-16.
  7. Koolman, J., Color Atlas of Biochemistry / J. Koolman, K. H. Röhm // Tieme. — 2005. — 476 p.
  8. Poryadin, G. V. Stress and pathology: Methodical development ; ed. by G. V. Poryadin. - M.: RGMU, 2009. - 23 с.
  9. Litwack, G., Human Biochemistry and Disease / G. Litwack, ed. // Academic Press. — 2008. — P. 1272.
  10. Carlsson, A. The occurrence, distribution and physiological role catecholamines in the nervous system / A. Carlsson // Pharmacol Rev. — 1959. — Vol. 11. — P. 490—493.
  11. Anokhin, K. V. Nobel Prize in Physiology and Medicine for 2000 / K. V. Anokhin // Journal "Nature". - 2001. - № 1.
  12. Ashmarin, I. P. Neurochemistry in Tables and Schemes / I. P. Ashmarin, N. D. Yeshenko, E. P. Karazeeva - M.: Examen, 2007. - 143 с.
  13. Seamans, J. Dopamine anatomy / J. Seamans // Scholarpedia. — 2007. — 2(6). — Р. 3737.
  14. Björklund, A. Dopamine neuron systems in the brain: an update trends / A. Björklund, S. B. Dunnett // Neurosci. — 2007. — Vol. 30. — P. 194—202.
  15. Shabanov, P. D. Dopamine and reinforcing systems of the brain / P. D. Shabanov, A. A. Lebedev, Sh. K. Meshcherov. - SPb.: Lan, 2002. - 208 с.
  16. Arias-Carrion, O. Dopamine, learning, and reward-seeking behavior / О. Arias-Carrion, Е. Pöppel // Acta Neurobiol Exp. — 2007. — Vol. 67. — P. 481—488.
  17. Seeman, P. Brain dopamine receptors / Р. Seeman // Pharmacol. Rev. — 1980. — Vol. 32. — P. 229—313.
  18. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter / [V. Fauchey, M. Jaber, M. G. Caron et al.] // Eur. J. Neurosci. — 2000. — Vol. 12. — P. 19—26.
  19. Textbook of Receptor Pharmacology. 2nd ed. (eds. J.C. Foreman and T. Johansen). — CRC Press, England, 2002. — 302 p.
  20. Cooper, J. R. The Biochemical Basis of Neuropharmacology / J. R. Cooper, J. R., F. E. Bloom, R. H. Roth // Oxford University Press. — 2002. — 416 p.
  21. Popova, N. S. Amphetamine function of the dopaminergic system and delta-sleep peptide / N. S. Popova, E. L. Dovedova // Ros. physiol. zhurn. im. I. M. Sechenov. -1998. - Т.84. - № 1-2. - С. 24 - 29.
  22. Parkinson's disease / [G. N. Kryzhanovsky, I. N. Karaban, S. V. Magayeva et al.]. - Moscow: Medicine, 2002. - 335 с.
  23. Orlovskaya, D. D. Neuroanatomy of schizophrenia at the present stage (review of foreign literature) / Orlovskaya D. D., Uranova N. A. // Zh. neuropathol. and psychiatr. D., Uranova N. A. // Zh. neuropathol. and psychiatr. - 1990. - Т. 90. - № 10. - С. 114-120.
  24. Faraone, S. Neurobiology of attention deficit hyperactivity disorder. / S. V. Faraone, J. Biederman // Biol Psychiatry. — 1998. — 44. — Vol. 10. — P. 951—958.
  25. Zykov, V. P. Tics of childhood / V. P. Zykov. - Moscow: Antidor AOZT, 2002. - 176 с.
  26. Hoekstra, P. J. Tic disorders and obsessive-compulsive disorder: is autoimmunity involved?/ P. J., Hoekstra, R. B. Minderaa // Int Rev Psychiatry. — 2005. — Vol. 17(6). — P. 497—502.
  27. Polunina, A. G. Mental dependence in drug addiction: the role of the mesocortico-limbic dopaminergic system / A. G. Polunina, D. M. Davidov, E. A. Brun // Journal of Neurology and Psychiatry. Korsakov. - 2007. - Т. 107. - № 2. - С. 70-75
  28. Berridge, K. C. What is role of dopamine in reward, hedonic, impact, reward learning or incentive salience?/ K. C. Berridge, T. E. Robinson // Brain Res Rev. — 1998. — Vol. 28. — 309—369.
  29. Inoue, A. Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy/ А. Inoue, Y. Nakata // Jap. J. Pharmacol. — 2001. — Vol. 86. — P. 376—380.
  30. Davis, K. L. Dopamine in schizophrenia: a review and reconceptualization / K. L. Davis, R. S. Kahn, C. Ko // Am. J. Psychiatry. — 1991. — Vol. 148. — P. 1474—1486.
  31. Willner, P. The dopamine hypothesis of schizophrenia: current status, future prospects / P. Willner // Int. Clin. Psychopharmacol. — 1997. — Vol. 12. — 297—308.
  32. Lieberman, J. A. Provocative tests with psychostimulant drugs in schizophrenia / J. A. Lieberman, J. M. Kane, J. Alvir // Psychopharmacology. — 1987. — Vol. 91. — P. 415—433.
  33. Seeman, P. Dopamine receptors and transporters in Parkinson’s disease and schizophrenia / P. Seeman, H. B. Niznik // FASEB J. — 1990. — Vol. 4. — P. 2737—2744.
  34. Pyatnitskaya, I. N. General and private narcology: Manual for doctors / I. N. Pyatnitskaya. - Moscow: Medicine, 2008. - 640 с.
  35. Genetic factors of predisposition to smoking: polymorphisms of genes of metabolism of dopamine, dopamine repeaters and CHRNA5 / [N. V. Mityushkina, E. N. Suspitsyn, Y. M. Ulybina et al] // Voprosy Onkologii. Appendix: Abstracts of the 6th Russian Conference on Fundamental Oncology "Petrovsky Readings - 2010", St. Petersburg, April 16, 2010. - 2010. - Т. 56. - № 2. - С. 34-35.
  36. Di Chiara, G. Reward system and addiction: what dopamine does and doesn’t do / G. Di Chiara, V. Bassareo // Curr Opin Pharmacol. — 2007. — Vol. 7. — P. 1—8.
  37. Wise, R. A. Dopamine, learning and motivation / R. A. Wise // Nat Rev Neurosci. — 2004. — Vol. 5. — P. 483—494.
  38. Olds, J. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain / J. Olds J., P. Milner // Journal of Comparative and Physiological Psychology. — 1954. — Vol.47. — P. 419—427.
  39. Molecular Biology of Drug Addiction. Edited by Rafael Maldonado // Humana Press Inc. — 2003. — 346 p.
  40. Voloshina, N. P. Mental and neurological disorders due to the use of homemade psychostimulant derived from the drug "Effect" / [N. P. Voloshina, V. I. Taitzlin, I. V. Linsky, et al] // Ukrainian Vissnik psycho-neurology. - 2000. - Vol. 8, vip. 2(24). - С. 74-76.
  41. Taitslin, V. I. Neurological aspects of opium addiction in imprisoned women / V. I. Taitslin, E. G. Matuzok // Addiction Biology. — 1998. — Vol. 3 — P. 315—319.
  42. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users / [J. M. Wilson, A. I. Levey, C. Bergeron et al.] // Ann. Neurol. — 1996. — Vol. 40. — P. 428—439.
  43. Cocaine self-administration in dopamine-transporter knockout mice / [B. A. Rocha, F. Fumagalli, R. R. Gainetdinovet et al.] // Nat. Neurosci. — 1998. — Vol. 1. — P. 132—137.